首页> 美国卫生研究院文献>Pharmaceutics >Nanostructured Lipid Carrier Gel for the Dermal Application of Lidocaine: Comparison of Skin Penetration Testing Methods
【2h】

Nanostructured Lipid Carrier Gel for the Dermal Application of Lidocaine: Comparison of Skin Penetration Testing Methods

机译:用于利多卡因皮肤应用的纳米结构脂质载体凝胶:皮肤渗透测试方法的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this research was to investigate the stability of a lidocaine-loaded nanostructured lipid carrier dispersion at different temperatures, formulate a nanostructured lipid carrier gel, and test the penetration profile of lidocaine from the nanostructured lipid carrier gel using different skin penetration modeling methods. The formulations were characterized by laser diffraction, rheological measurements and microscopic examinations. Various in vitro methods were used to study drug release, diffusion and penetration. Two types of vertical Franz diffusion cells with three different membranes, including cellulose, Strat-M®, and heat separated human epidermis were used and compared to the Skin-parallel artificial membrane permeability assay (PAMPA) method. Results indicated that the nanostructured lipid carrier dispersion had to be gelified as soon as possible for proper stability. Both the Skin-PAMPA model and Strat-M® membranes correlated favorably with heat separated human epidermis in this research, with the Strat-M® membranes sharing the most similar drug permeability profile to an ex vivo human skin model. Our experimental findings suggest that even when the best available in vitro experiment is selected for modeling human skin penetration to study nanostructured lipid carrier gel systems, relevant in vitro/in vivo correlation should be made to calculate the drug release/permeation in vivo. Future investigations in this field are still needed to demonstrate the influence of membranes and equipment from other classes on other drug candidates.
机译:这项研究的目的是研究负载利多卡因的纳米结构脂质载体分散体在不同温度下的稳定性,配制纳米结构脂质载体凝胶,并使用不同的皮肤渗透建模方法测试利多卡因从纳米结构脂质载体凝胶的渗透特性。通过激光衍射,流变学测量和显微镜检查来表征制剂。各种体外方法被用来研究药物的释放,扩散和渗透。使用两种具有三种不同膜的垂直Franz扩散池,包括纤维素,Strat-M ®和热分离的人表皮,并将其与平行皮肤人工膜通透性测定(PAMPA)方法进行比较。结果表明,为了适当的稳定性,纳米结构的脂质载体分散体必须尽快凝胶化。在这项研究中,Skin-PAMPA模型和Strat-M ®膜均与热分离的人类表皮良好相关,而Strat-M ®膜具有最相似的药物渗透性剖析到离体人体皮肤模型。我们的实验结果表明,即使选择了最佳的体外实验来模拟人体皮肤渗透以研究纳米结构脂质载体凝胶系统,也应进行相关的体内/体外相关性以计算药物在体内的释放/渗透。仍然需要对该领域进行进一步的研究,以证明其他类别的膜和设备对其他候选药物的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号